Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-088494
Filing Date
2024-04-05
Accepted
2024-04-05 16:20:26
Documents
11
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A d752944dpre14a.htm PRE 14A 423159
2 GRAPHIC g752944dsp2a.jpg GRAPHIC 1041
3 GRAPHIC g752944g56o91.jpg GRAPHIC 35844
4 GRAPHIC g752944img1.jpg GRAPHIC 2877
5 GRAPHIC g752944img2.jpg GRAPHIC 29991
6 GRAPHIC g752944img3.jpg GRAPHIC 1540
7 GRAPHIC g752944img4.jpg GRAPHIC 1324
8 GRAPHIC g752944img5.jpg GRAPHIC 1299
9 GRAPHIC g752944img6.jpg GRAPHIC 1540
10 GRAPHIC g752944img7.jpg GRAPHIC 895
11 GRAPHIC g752944img8.jpg GRAPHIC 6094
  Complete submission text file 0001193125-24-088494.txt   535312
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40800 | Film No.: 24826790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)